ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005

NCI spends A Third Of Its Budget On Prevention

May 15, 1992